Stork Capital is an independent, Geneva-based asset manager specializing in long-term wealth management solutions for private clients, family offices, and founders. The firm focuses on supplementing the steady gains of public markets with diverse opportunities in private markets to achieve higher long-term returns. Stork Capital engages primarily in Series A and Series B investment rounds, offering traditional wealth management services, including portfolio management, merchant banking, and wealth planning.
Notable portfolio companies include Shoreline Biosciences, which has raised $183 million. The firm boasts a team of experienced portfolio managers with backgrounds in prestigious institutions such as UBS, Credit Suisse, and Merrill Lynch. Stork Capital's investment philosophy emphasizes a diversified approach to maximize returns while managing risk. They provide unique value-add services to their portfolio companies, leveraging their extensive expertise in private banking and multi-family office management.
Stork Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
